<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="brief-report">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2016.01655</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Perspective</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Phylogenetic Insights into the Functional Relationship between Primate Lentiviral Reverse Transcriptase and Accessory Proteins Vpx/Vpr</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Sakai</surname> <given-names>Yosuke</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/51873/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Doi</surname> <given-names>Naoya</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/18576/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Miyazaki</surname> <given-names>Yasuyuki</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/18771/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Adachi</surname> <given-names>Akio</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/14796/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Nomaguchi</surname> <given-names>Masako</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/17573/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Microbiology, Tokushima University Graduate School of Medical Science</institution> <country>Tokushima, Japan</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science</institution> <country>Tokyo, Japan</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: <italic>Akihide Ryo, Yokohama City University, Japan</italic></p></fn>
<fn fn-type="edited-by"><p>Reviewed by: <italic>Hiroaki Takeuchi, Tokyo Medical and Dental University, Japan; Ayumi Kudoh, Yokohama City University, Japan</italic></p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x002A;Correspondence: <italic>Akio Adachi, <email>adachi@tokushima-u.ac.jp</email> Masako Nomaguchi, <email>nomaguchi@tokushima-u.ac.jp</email></italic></p></fn>
<fn fn-type="other" id="fn002"><p>This article was submitted to Virology, a section of the journal Frontiers in Microbiology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>7</volume>
<elocation-id>1655</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>08</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>10</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2016 Sakai, Doi, Miyazaki, Adachi and Nomaguchi.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Sakai, Doi, Miyazaki, Adachi and Nomaguchi</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>The efficiency of reverse transcription to synthesize viral DNA in infected cells greatly influences replication kinetics of retroviruses. However, viral replication in non-dividing cells such as resting T cells and terminally differentiated macrophages is potently and kinetically restricted by a host antiviral factor designated SAMHD1 (sterile alpha motif and HD-domain containing protein 1). SAMHD1 reduces cellular deoxynucleoside triphosphate (dNTP) pools and affects viral reverse transcription step. Human immunodeficiency virus type 2 (HIV-2) and some simian immunodeficiency viruses (SIVs) have Vpx or Vpr to efficiently degrade SAMHD1. Interestingly, the reverse transcriptase (RT) derived from HIV-1 that encodes no anti-SAMHD1 proteins has been previously demonstrated to uniquely exhibit a high enzymatic activity. It is thus not irrational to assume that some viruses may have acquired or lost the specific RT property to better adapt themselves to the low dNTP environments confronted in non-dividing cells. This adaptation process may probably be correlated with the SAMHD1-antagonizing ability by viruses. In this report, we asked whether such adaptive events can be inferable from Vpx/Vpr and RT phylogenetic trees overlaid with SAMHD1-degrading capacity of Vpx/Vpr and with kinetic characteristics of RT. Resultant two trees showed substantially similar clustering patterns, and therefore suggested that the properties of RT and Vpx/Vpr can be linked. In other words, HIV/SIVs may possess their own RT proteins to adequately react to various dNTP circumstances in target cells.</p>
</abstract>
<kwd-group>
<kwd>HIV</kwd>
<kwd>SIV</kwd>
<kwd>Vpx</kwd>
<kwd>Vpr</kwd>
<kwd>RT</kwd>
<kwd>SAMHD1</kwd>
<kwd>dNTP</kwd>
</kwd-group>
<contract-num rid="cn001">JP26293104</contract-num>
<contract-sponsor id="cn001">Japan Society for the Promotion of Science<named-content content-type="fundref-id">10.13039/501100001691</named-content></contract-sponsor>
<counts>
<fig-count count="2"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="15"/>
<page-count count="5"/>
<word-count count="0"/>
</counts>
</article-meta>
</front>
<body>
<sec><title>Introduction</title>
<p>Accessory proteins of various human immunodeficiency viruses/simian immunodeficiency viruses (HIV/SIVs) are believed to be essential for optimal viral replication, persistence, and pathogenicity <italic>in vivo</italic> (<xref ref-type="bibr" rid="B12">Matheson et al., 2016</xref>). Vpx was least well studied among the five accessory proteins (Vif, Vpx, Vpr, Vpu, and Nef) for its functional role and the underlying molecular basis until the recent identification of cellular anti-viral factor SAMHD1 as a target for Vpx (<xref ref-type="bibr" rid="B5">Hrecka et al., 2011</xref>; <xref ref-type="bibr" rid="B7">Laguette et al., 2011</xref>). Extensive studies since then have generated a series of critical findings to understand the interaction of Vpx and SAMHD1 (<xref ref-type="bibr" rid="B4">Goldstone et al., 2011</xref>; <xref ref-type="bibr" rid="B5">Hrecka et al., 2011</xref>; <xref ref-type="bibr" rid="B7">Laguette et al., 2011</xref>, <xref ref-type="bibr" rid="B6">2012</xref>; <xref ref-type="bibr" rid="B1">Baldauf et al., 2012</xref>; <xref ref-type="bibr" rid="B2">Descours et al., 2012</xref>; <xref ref-type="bibr" rid="B8">Lahouassa et al., 2012</xref>; <xref ref-type="bibr" rid="B11">Lim et al., 2012</xref>; <xref ref-type="bibr" rid="B15">St Gelais et al., 2012</xref>; <xref ref-type="bibr" rid="B10">Lenzi et al., 2014</xref>, <xref ref-type="bibr" rid="B9">2015</xref>): (1) all Vpx and some Vpr proteins derived from various HIV/SIVs target SAMHD1 for proteasomal degradation; (2) SAMHD1 reduces cellular deoxynucleoside triphosphate (dNTP) pools to a level similar to that observed in non-dividing myeloid and resting T cells; (3) HIV-1 reverse transcriptase (RT) shows a high binding affinity to dNTPs relative to those from other lentiviruses. Of note here, HIV-1 can replicate in macrophages to some extent, and lacks SAMHD1-degrading activity. Thus, HIV-1 appears to be unique among primate lentiviruses to act against SAMHD1.</p>
<p>On the basis of the experimental results summarized above, it would hold true to hypothesize that some specific viruses have adapted themselves to better fit the physiological environments in non-dividing cells. Therefore, we here have performed phylogenetic analyses using distinct Vpx/Vpr and RT proteins from viruses with/without anti-SAMHD1 activity. To this end, we phylogenetically examined the target viral proteins (Vpx/Vpr and RT with no sequence ambiguity) derived from three types of diverse SIVs based on their genome features relating to <italic>vpx, vpr</italic>, and <italic>vpu</italic> genes (<xref ref-type="bibr" rid="B3">Fujita et al., 2010</xref>; <xref ref-type="bibr" rid="B13">Sakai et al., 2016</xref>) as follows. (1) &#x201C;Prototype viruses&#x201D; carrying <italic>vpr</italic> gene analyzed here were SIVagm (isolated from the African green monkey), SIVmnd-1 (mandrill), SIVlst (l&#x2019;Hoest&#x2019;s monkey), SIVsun (sun-tailed monkey), SIVsyk (Sykes&#x2019; monkey), SIVdeb (DeBrazza&#x2019;s monkey), SIVtal (talapoin monkey), SIVasc (red-tailed guenon), SIVcol (colobus monkey), SIVwrc (western red colobus), and SIVolc (olive colobus). (2) &#x201C;HIV-1 type viruses&#x201D; carrying <italic>vpr</italic> and <italic>vpu</italic> genes analyzed here were, SIVcpz (chimpanzee), SIVgor (gorilla), SIVgsn (greater spot-nosed monkey), SIVmon (mona monkey), SIVmus (mustached monkey), and SIVden (Dent&#x2019;s monkey). (3) &#x201C;HIV-2 type viruses&#x201D; carrying <italic>vpx</italic> and <italic>vpr</italic> genes analyzed here were SIVsmm (sooty mangabey monkey), SIVmac (macaque monkey), SIVmne (pig-tailed macaque), SIVstm (stump-tailed macaque), SIVrcm (red-capped mangabey), SIVmnd-2 (mandrill), and SIVdrl (drill monkey).</p>
</sec>
<sec><title>Phylogeny of Vpx/Vpr Proteins Derived From Viruses With/Without Samhd1-Degrading Activity</title>
<p>Early studies have shown that Vpx is essential for HIV-2 and SIVmac replication in primary non-dividing cells (<xref ref-type="bibr" rid="B3">Fujita et al., 2010</xref>; <xref ref-type="bibr" rid="B14">Schaller et al., 2014</xref>). Subsequent studies have revealed that Vpx enhances viral DNA synthesis by inducing proteasomal degradation of an anti-viral factor in those cells (<xref ref-type="bibr" rid="B3">Fujita et al., 2010</xref>; <xref ref-type="bibr" rid="B14">Schaller et al., 2014</xref>). It is now established that the anti-viral factor SAMHD1 abundantly present in the non-dividing cells is degraded by Vpx from HIV-2 type viruses and Vpr from some prototype viruses (<xref ref-type="bibr" rid="B6">Laguette et al., 2012</xref>; <xref ref-type="bibr" rid="B11">Lim et al., 2012</xref>). There are no Vpr proteins with SAMHD1-degrading activity derived from HIV-1 and HIV-2 type viruses except for Vpr from SIVmus (HIV-1 type) (<xref ref-type="bibr" rid="B6">Laguette et al., 2012</xref>; <xref ref-type="bibr" rid="B11">Lim et al., 2012</xref>).</p>
<p>In order to easily see the genetic background for the results described above (<xref ref-type="bibr" rid="B6">Laguette et al., 2012</xref>; <xref ref-type="bibr" rid="B11">Lim et al., 2012</xref>), we also inferred a bootstrap phylogenetic tree of Vpx/Vpr proteins from diverse HIV/SIVs by the neighbor-joining method as previously described (<xref ref-type="bibr" rid="B13">Sakai et al., 2016</xref>), and the proteins with/without SAMHD1-degrading activity were highlighted by blue and red letters, respectively. Viruses without Vpx (prototype and HIV-1 type viruses) were analyzed for their Vpr proteins, and viruses with both Vpx and Vpr (HIV-2 type viruses) were examined for their Vpx proteins. As shown in <bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>, Vpx/Vpr proteins from viruses with SAMHD1-degrading activity (viral groups: HIV-2, SIVsmm/mac/mne/stm, SIVrcm/mnd-2/drl, SIVagm, SIVmus/gsn/den/mon, and SIVdeb/syk/tal/asc) clearly formed different clusters from those by Vpr proteins from viruses without SAMHD1-degrading activity (viral groups: HIV-1, SIVcpz/gor, SIVmnd-1/lst/sun, and SIVolc/wrc/col). No virus strains without SAMHD1-degrading activity were found in the clusters with the activity and the opposite was true. These results suggested that HIV/SIVs with/without anti-SAMHD1 activity diverged at some time point in the past.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p><bold>Phylogeny of Vpx/Vpr proteins derived from various human immunodeficiency viruses/simian immunodeficiency viruses (HIV/SIVs).</bold> Phylogenetic tree based on diverse Vpx/Vpr proteins was constructed as previously described (<xref ref-type="bibr" rid="B13">Sakai et al., 2016</xref>), and is shown together with SAMHD1 (sterile alpha motif and HD-domain containing protein 1)-degrading activity. Viral clones with/without SAMHD1-degrading activity (<xref ref-type="bibr" rid="B6">Laguette et al., 2012</xref>; <xref ref-type="bibr" rid="B11">Lim et al., 2012</xref>) are indicated by blue and red letters, respectively. Note that Vpr proteins from HIV-2 type viruses (HIV-2, SIVsmm/mac/mne/stm, and SIVrcm/mnd-2/drl) are excluded from this tree for simplicity and clarity. Branches were calculated from 1000 bootstrap replicates, and the bootstrap values are labeled on the major branches. Scale bar represents the genetic distance. For virus designations, origins, and types, see the text (Introduction). Amino acid sequences were obtained from the HIV sequence database at Los Alamos National Laboratory (<ext-link ext-link-type="uri" xlink:href="http://www.hiv.lanl.gov">http://www.hiv.lanl.gov</ext-link>) or from the GenBank (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov</ext-link>).</p></caption>
<graphic xlink:href="fmicb-07-01655-g001.tif"/>
</fig>
</sec>
<sec><title>Phylogeny of Rt Proteins Derived From Viruses With/Without Samhd1-Degrading Activity</title>
<p>Human immunodeficiency virus type 1 does not encode any anti-SAMHD1 proteins as described above, which appears to be disadvantageous to the virus for efficient replication in target cells, especially in non-dividing myeloid and resting T cells. Nonetheless, HIV-1 grows well in humans and is markedly pathogenic for humans. While the mechanism(s) underlying for this viral property remains elusive, one could postulate, as a likely possibility, that the high growth ability of HIV-1 is attributable to its relatively high RT activity (<xref ref-type="bibr" rid="B14">Schaller et al., 2014</xref>). Indeed, it has been reported that HIV-1 RT is more active in synthesizing viral DNA than the other viral RT proteins derived from viruses with SAMHD1-degrading ability (<xref ref-type="bibr" rid="B10">Lenzi et al., 2014</xref>, <xref ref-type="bibr" rid="B9">2015</xref>).</p>
<p>We therefore constructed a phylogenetic tree of various RT proteins from viruses with/without anti-SAMHD1 activity in order to predict their evolutional positions as described above (<xref ref-type="bibr" rid="B13">Sakai et al., 2016</xref>), and the result was shown in <bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>. RT proteins from viruses without anti-SAMHD1 activity (viral groups: HIV-1, SIVcpz/gor, SIVmnd-1/lst/sun, and SIVolc/wrc/col) and those from viruses with the activity (viral groups: SIVrcm/mnd-2/drl, SIVagm, SIVmus/gsn/den/mon, SIVdeb/syk/tal/asc, HIV-2, and SIVsmm/mac/mne/stm) separately formed clusters as observed in the Vpx/Vpr tree (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). Importantly, viruses with a high RT activity (<xref ref-type="bibr" rid="B10">Lenzi et al., 2014</xref>, <xref ref-type="bibr" rid="B9">2015</xref>) were confined to the HIV-1 cluster without SAMHD1-degrading ability. In contrast, viruses with a low RT activity (<xref ref-type="bibr" rid="B10">Lenzi et al., 2014</xref>, <xref ref-type="bibr" rid="B9">2015</xref>) were found in various virus clusters with SAMHD1-degrading ability (SIVagm, HIV-2, SIVmac, and SIVmne). While not included in this phylogenetic tree due to the sequence unavailability to us, two more HIV-1 strains (92RW and 93IN) and two other HIV-2/SIVmne strains (Rod10 and 170) were reported to have RT proteins with a high and low enzymatic activity, respectively (<xref ref-type="bibr" rid="B10">Lenzi et al., 2014</xref>). Together with the result in <bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>, our phylogenetic tree here is consistent with a hypothesis that the ability of Vpx/Vpr proteins from various HIV/SIVs to degrade SAMHD1 and the different enzymatic activity of RT proteins from various HIV/SIVs are intimately linked.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p><bold>Phylogeny of reverse transcriptase (RT) proteins derived from various HIV/SIVs.</bold> Phylogenetic tree based on diverse RT proteins was constructed as previously described (<xref ref-type="bibr" rid="B13">Sakai et al., 2016</xref>), and is shown together with SAMHD1-degrading and RT activities. Viral clones with/without SAMHD1-degrading activity (<xref ref-type="bibr" rid="B6">Laguette et al., 2012</xref>; <xref ref-type="bibr" rid="B11">Lim et al., 2012</xref>) are indicated by blue and red letters, respectively. In addition, viral clones experimentally tested for RT activity (<xref ref-type="bibr" rid="B10">Lenzi et al., 2014</xref>, <xref ref-type="bibr" rid="B9">2015</xref>) are indicated by boldface type letters. Note that RT proteins from the HIV-1 group show a higher enzymatic activity relative to those from the other viral groups examined (<xref ref-type="bibr" rid="B10">Lenzi et al., 2014</xref>, <xref ref-type="bibr" rid="B9">2015</xref>). Branches were calculated from 1000 bootstrap replicates, and the bootstrap values are labeled on the major branches. Scale bar represents the genetic distance. For virus designations, origins, and types, see the text (Introduction). Amino acid sequences were obtained from the HIV sequence database at Los Alamos National Laboratory (<ext-link ext-link-type="uri" xlink:href="http://www.hiv.lanl.gov">http://www.hiv.lanl.gov</ext-link>) or from the GenBank (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov</ext-link>).</p></caption>
<graphic xlink:href="fmicb-07-01655-g002.tif"/>
</fig>
</sec>
<sec><title>Concluding Remarks</title>
<p>Primate lentiviral diversification is frequently accompanied by functional alterations of viral proteins required for efficient viral replication in different cellular environments, which can provide virologically essential informations to understand the inter-/intra-species transmission and adaptation processes. In this report, we have described a potential link between the SAMHD1-degrading activity of Vpx/Vpr proteins and the enzymatic activity of RT proteins. Our phylogenetic analyses (<bold>Figures <xref ref-type="fig" rid="F1">1</xref></bold> and <bold><xref ref-type="fig" rid="F2">2</xref></bold>) are consistent with a scenario that HIV-1 without anti-SAMHD1 activity may already have or have acquired RT with enhanced enzymatic activity. However, because viral strains experimentally examined for their anti-SAMHD1 and RT activities through biochemical and molecular biological approaches are limited so far, it would be too early to draw a clear conclusion on this issue. Extensive experimental studies are required to obtain decisive results.</p>
</sec>
<sec><title>Author Contributions</title>
<p>YS, AA, and MN designed the research. YS performed the phylogenetic analysis. YS, ND, YM, AA, and MN analyzed and discussed the results. YS, AA, and MN wrote the manuscript.</p>
</sec>
<sec><title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer AK and handling Editor declared their shared affiliation, and the handling Editor states that the process nevertheless met the standards of a fair and objective review.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This study is supported in part by a research grant from the Japan Society for the Promotion of Science (JSPS KAKENHI: Grant Number JP26293104).</p>
</fn>
</fn-group>
<ack>
<p>We thank Ms. Kazuko Yoshida (Department of Microbiology, Tokushima University Graduate School of Medical Science, Tokushima, Japan) for her editorial assistance.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baldauf</surname> <given-names>H. M.</given-names></name> <name><surname>Pan</surname> <given-names>X.</given-names></name> <name><surname>Erikson</surname> <given-names>E.</given-names></name> <name><surname>Schmidt</surname> <given-names>S.</given-names></name> <name><surname>Daddacha</surname> <given-names>W.</given-names></name> <name><surname>Burggraf</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>SAMHD1 restricts HIV-1 infection in resting CD4+ T cells.</article-title> <source><italic>Nat. Med.</italic></source> <volume>18</volume> <fpage>1682</fpage>&#x2013;<lpage>1687</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2964</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Descours</surname> <given-names>B.</given-names></name> <name><surname>Cribier</surname> <given-names>A.</given-names></name> <name><surname>Chable-Bessia</surname> <given-names>C.</given-names></name> <name><surname>Ayinde</surname> <given-names>D.</given-names></name> <name><surname>Rice</surname> <given-names>G.</given-names></name> <name><surname>Crow</surname> <given-names>Y.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells.</article-title> <source><italic>Retrovirology</italic></source> <volume>9</volume>:<issue>87</issue>. <pub-id pub-id-type="doi">10.1186/1742-4690-9-87</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname> <given-names>M.</given-names></name> <name><surname>Otsuka</surname> <given-names>M.</given-names></name> <name><surname>Nomaguchi</surname> <given-names>M.</given-names></name> <name><surname>Adachi</surname> <given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Multifaceted activity of HIV Vpr/Vpx proteins: the current view of their virological functions.</article-title> <source><italic>Rev. Med. Virol.</italic></source> <volume>20</volume> <fpage>68</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1002/rmv.636</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldstone</surname> <given-names>D.</given-names></name> <name><surname>Ennis-Adeniran</surname> <given-names>V.</given-names></name> <name><surname>Hedden</surname> <given-names>J.</given-names></name> <name><surname>Groom</surname> <given-names>H.</given-names></name> <name><surname>Rice</surname> <given-names>G.</given-names></name> <name><surname>Christodoulou</surname> <given-names>E.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.</article-title> <source><italic>Nature</italic></source> <volume>480</volume> <fpage>379</fpage>&#x2013;<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1038/nature10623</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hrecka</surname> <given-names>K.</given-names></name> <name><surname>Hao</surname> <given-names>C.</given-names></name> <name><surname>Gierszewska</surname> <given-names>M.</given-names></name> <name><surname>Swanson</surname> <given-names>S. K.</given-names></name> <name><surname>Kesik-Brodacka</surname> <given-names>M.</given-names></name> <name><surname>Srivastava</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.</article-title> <source><italic>Nature</italic></source> <volume>474</volume> <fpage>658</fpage>&#x2013;<lpage>661</lpage>. <pub-id pub-id-type="doi">10.1038/nature10195</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laguette</surname> <given-names>N.</given-names></name> <name><surname>Rahm</surname> <given-names>N.</given-names></name> <name><surname>Sobhian</surname> <given-names>B.</given-names></name> <name><surname>Chable-Bessia</surname> <given-names>C.</given-names></name> <name><surname>M&#x00FC;nch</surname> <given-names>J.</given-names></name> <name><surname>Snoeck</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein.</article-title> <source><italic>Cell Host Microbe</italic></source> <volume>11</volume> <fpage>205</fpage>&#x2013;<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2012.01.007</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laguette</surname> <given-names>N.</given-names></name> <name><surname>Sobhian</surname> <given-names>B.</given-names></name> <name><surname>Casartelli</surname> <given-names>N.</given-names></name> <name><surname>Ringeard</surname> <given-names>M.</given-names></name> <name><surname>Chable-Bessia</surname> <given-names>C.</given-names></name> <name><surname>S&#x00E9;g&#x00E9;ral</surname> <given-names>E.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx.</article-title> <source><italic>Nature</italic></source> <volume>474</volume> <fpage>654</fpage>&#x2013;<lpage>657</lpage>. <pub-id pub-id-type="doi">10.1038/nature10117</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lahouassa</surname> <given-names>H.</given-names></name> <name><surname>Daddacha</surname> <given-names>W.</given-names></name> <name><surname>Hofmann</surname> <given-names>H.</given-names></name> <name><surname>Ayinde</surname> <given-names>D.</given-names></name> <name><surname>Logue</surname> <given-names>E.</given-names></name> <name><surname>Dragin</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates.</article-title> <source><italic>Nat. Immunol.</italic></source> <volume>13</volume> <fpage>223</fpage>&#x2013;<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2236</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lenzi</surname> <given-names>G.</given-names></name> <name><surname>Domaoal</surname> <given-names>R.</given-names></name> <name><surname>Kim</surname> <given-names>D.-H.</given-names></name> <name><surname>Schinazi</surname> <given-names>R.</given-names></name> <name><surname>Kim</surname> <given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>Mechanistic and kinetic differences between reverse transcriptases of Vpx coding and non-coding lentiviruses.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>290</volume> <fpage>30078</fpage>&#x2013;<lpage>30086</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.691576</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lenzi</surname> <given-names>G. M.</given-names></name> <name><surname>Domaoal</surname> <given-names>R. A.</given-names></name> <name><surname>Kim</surname> <given-names>D.-H.</given-names></name> <name><surname>Schinazi</surname> <given-names>R. F.</given-names></name> <name><surname>Kim</surname> <given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Kinetic variations between reverse transcriptases of viral protein X coding and noncoding lentiviruses.</article-title> <source><italic>Retrovirology</italic></source> <volume>11</volume>:<issue>111</issue>. <pub-id pub-id-type="doi">10.1186/s12977-014-0111-y</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname> <given-names>E. S.</given-names></name> <name><surname>Fregoso</surname> <given-names>O. I.</given-names></name> <name><surname>McCoy</surname> <given-names>C. O.</given-names></name> <name><surname>Matsen</surname> <given-names>F. A.</given-names></name> <name><surname>Malik</surname> <given-names>H. S.</given-names></name> <name><surname>Emerman</surname> <given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx.</article-title> <source><italic>Cell Host Microbe</italic></source> <volume>11</volume> <fpage>194</fpage>&#x2013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2012.01.004</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matheson</surname> <given-names>N. J.</given-names></name> <name><surname>Greenwood</surname> <given-names>E. J. D.</given-names></name> <name><surname>Lehner</surname> <given-names>P. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Manipulation of immunometabolism by HIV &#x2013; accessories to the crime?</article-title> <source><italic>Curr. Opin. Virol.</italic></source> <volume>19</volume> <fpage>65</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.coviro.2016.06.014</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname> <given-names>Y.</given-names></name> <name><surname>Miyake</surname> <given-names>A.</given-names></name> <name><surname>Doi</surname> <given-names>N.</given-names></name> <name><surname>Sasada</surname> <given-names>H.</given-names></name> <name><surname>Miyazaki</surname> <given-names>Y.</given-names></name> <name><surname>Adachi</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Expression profiles of Vpx/Vpr proteins are co-related with the primate lentiviral lineage.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>7</volume>:<issue>1211</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2016.01211</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schaller</surname> <given-names>T.</given-names></name> <name><surname>Bauby</surname> <given-names>H.</given-names></name> <name><surname>Hu&#x00E9;</surname> <given-names>S.</given-names></name> <name><surname>Malim</surname> <given-names>M. H.</given-names></name> <name><surname>Goujon</surname> <given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>New insights into an X-traordinary viral protein.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>5</volume>:<issue>126</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2014.00126</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>St Gelais</surname> <given-names>C.</given-names></name> <name><surname>De Silva</surname> <given-names>S.</given-names></name> <name><surname>Amie</surname> <given-names>S. M.</given-names></name> <name><surname>Coleman</surname> <given-names>C. M.</given-names></name> <name><surname>Hoy</surname> <given-names>H.</given-names></name> <name><surname>Hollenbaugh</surname> <given-names>J. A.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferons.</article-title> <source><italic>Retrovirology</italic></source> <volume>9</volume>:<issue>105</issue>. <pub-id pub-id-type="doi">10.1186/1742-4690-9-105</pub-id></citation></ref>
</ref-list>
</back>
</article>